img

Global Conjugate Vaccine Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Conjugate Vaccine Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Vaccines are used to prevent diseases by invoking an immune response to an antigen, the foreign part of a bacteria or virus that the immune system recognizes. Conjugate vaccines combine a weak antigen with a strong antigen as a carrier so that the immune system has a stronger response to the weak antigen.
Conjugate Vaccine report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Conjugate Vaccine market is projected to reach US$ 12490 million in 2034, increasing from US$ 9995.1 million in 2022, with the CAGR of 3.2% during the period of 2024 to 2034. Demand from Children and Adult are the major drivers for the industry.
Market competition is intense. Pfizer, GSK, Sanofi, Merck, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers. Top 5 manufacturers accounted for 86.11% market share in 2019.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Conjugate Vaccine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, End Users and Regions Listed in the Report



By Company


Pfizer
GSK
Sanofi
Merck
Walvax Biotechnology
Royal (Wuxi) Bio-Pharmaceutical
Bharat Biotech
Zhifei Biologic
Segment by Type
Hib Vaccine
Meningococcal Vaccine
Pneumococcal Vaccine
Others
Segment by End Users
Children
Adult

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Conjugate Vaccine market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Conjugate Vaccine, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Conjugate Vaccine industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Conjugate Vaccine in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product End Users, Volume and Revenue analysis of Each End Users in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Conjugate Vaccine introduction, etc. Conjugate Vaccine Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Conjugate Vaccine market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Conjugate Vaccine Market Overview
1.1 Conjugate Vaccine Product Overview
1.2 Conjugate Vaccine Market Segment by Type
1.2.1 Hib Vaccine
1.2.2 Meningococcal Vaccine
1.2.3 Pneumococcal Vaccine
1.2.4 Others
1.3 Global Conjugate Vaccine Market Size by Type
1.3.1 Global Conjugate Vaccine Market Size Overview by Type (2018-2034)
1.3.2 Global Conjugate Vaccine Historic Market Size Review by Type (2018-2024)
1.3.3 Global Conjugate Vaccine Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Conjugate Vaccine Sales Breakdown by Type (2018-2024)
1.4.2 Europe Conjugate Vaccine Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Conjugate Vaccine Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Conjugate Vaccine Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Conjugate Vaccine Sales Breakdown by Type (2018-2024)
2 Global Conjugate Vaccine Market Competition by Company
2.1 Global Top Players by Conjugate Vaccine Sales (2018-2024)
2.2 Global Top Players by Conjugate Vaccine Revenue (2018-2024)
2.3 Global Top Players by Conjugate Vaccine Price (2018-2024)
2.4 Global Top Manufacturers Conjugate Vaccine Manufacturing Base Distribution, Sales Area, Product Type
2.5 Conjugate Vaccine Market Competitive Situation and Trends
2.5.1 Conjugate Vaccine Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Conjugate Vaccine Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Conjugate Vaccine as of 2022)
2.7 Date of Key Manufacturers Enter into Conjugate Vaccine Market
2.8 Key Manufacturers Conjugate Vaccine Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Conjugate Vaccine Status and Outlook by Region
3.1 Global Conjugate Vaccine Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Conjugate Vaccine Historic Market Size by Region
3.2.1 Global Conjugate Vaccine Sales in Volume by Region (2018-2024)
3.2.2 Global Conjugate Vaccine Sales in Value by Region (2018-2024)
3.2.3 Global Conjugate Vaccine Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Conjugate Vaccine Forecasted Market Size by Region
3.3.1 Global Conjugate Vaccine Sales in Volume by Region (2024-2034)
3.3.2 Global Conjugate Vaccine Sales in Value by Region (2024-2034)
3.3.3 Global Conjugate Vaccine Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Conjugate Vaccine by End Users
4.1 Conjugate Vaccine Market Segment by End Users
4.1.1 Children
4.1.2 Adult
4.2 Global Conjugate Vaccine Market Size by End Users
4.2.1 Global Conjugate Vaccine Market Size Overview by End Users (2018-2034)
4.2.2 Global Conjugate Vaccine Historic Market Size Review by End Users (2018-2024)
4.2.3 Global Conjugate Vaccine Forecasted Market Size by End Users (2024-2034)
4.3 Key Regions Market Size Segment by End Users
4.3.1 North America Conjugate Vaccine Sales Breakdown by End Users (2018-2024)
4.3.2 Europe Conjugate Vaccine Sales Breakdown by End Users (2018-2024)
4.3.3 Asia-Pacific Conjugate Vaccine Sales Breakdown by End Users (2018-2024)
4.3.4 Latin America Conjugate Vaccine Sales Breakdown by End Users (2018-2024)
4.3.5 Middle East and Africa Conjugate Vaccine Sales Breakdown by End Users (2018-2024)
5 North America Conjugate Vaccine by Country
5.1 North America Conjugate Vaccine Historic Market Size by Country
5.1.1 North America Conjugate Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Conjugate Vaccine Sales in Volume by Country (2018-2024)
5.1.3 North America Conjugate Vaccine Sales in Value by Country (2018-2024)
5.2 North America Conjugate Vaccine Forecasted Market Size by Country
5.2.1 North America Conjugate Vaccine Sales in Volume by Country (2024-2034)
5.2.2 North America Conjugate Vaccine Sales in Value by Country (2024-2034)
6 Europe Conjugate Vaccine by Country
6.1 Europe Conjugate Vaccine Historic Market Size by Country
6.1.1 Europe Conjugate Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Conjugate Vaccine Sales in Volume by Country (2018-2024)
6.1.3 Europe Conjugate Vaccine Sales in Value by Country (2018-2024)
6.2 Europe Conjugate Vaccine Forecasted Market Size by Country
6.2.1 Europe Conjugate Vaccine Sales in Volume by Country (2024-2034)
6.2.2 Europe Conjugate Vaccine Sales in Value by Country (2024-2034)
7 Asia-Pacific Conjugate Vaccine by Region
7.1 Asia-Pacific Conjugate Vaccine Historic Market Size by Region
7.1.1 Asia-Pacific Conjugate Vaccine Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Conjugate Vaccine Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Conjugate Vaccine Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Conjugate Vaccine Forecasted Market Size by Region
7.2.1 Asia-Pacific Conjugate Vaccine Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Conjugate Vaccine Sales in Value by Region (2024-2034)
8 Latin America Conjugate Vaccine by Country
8.1 Latin America Conjugate Vaccine Historic Market Size by Country
8.1.1 Latin America Conjugate Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Conjugate Vaccine Sales in Volume by Country (2018-2024)
8.1.3 Latin America Conjugate Vaccine Sales in Value by Country (2018-2024)
8.2 Latin America Conjugate Vaccine Forecasted Market Size by Country
8.2.1 Latin America Conjugate Vaccine Sales in Volume by Country (2024-2034)
8.2.2 Latin America Conjugate Vaccine Sales in Value by Country (2024-2034)
9 Middle East and Africa Conjugate Vaccine by Country
9.1 Middle East and Africa Conjugate Vaccine Historic Market Size by Country
9.1.1 Middle East and Africa Conjugate Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Conjugate Vaccine Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Conjugate Vaccine Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Conjugate Vaccine Forecasted Market Size by Country
9.2.1 Middle East and Africa Conjugate Vaccine Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Conjugate Vaccine Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Pfizer
10.1.1 Pfizer Company Information
10.1.2 Pfizer Introduction and Business Overview
10.1.3 Pfizer Conjugate Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Pfizer Conjugate Vaccine Products Offered
10.1.5 Pfizer Recent Development
10.2 GSK
10.2.1 GSK Company Information
10.2.2 GSK Introduction and Business Overview
10.2.3 GSK Conjugate Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.2.4 GSK Conjugate Vaccine Products Offered
10.2.5 GSK Recent Development
10.3 Sanofi
10.3.1 Sanofi Company Information
10.3.2 Sanofi Introduction and Business Overview
10.3.3 Sanofi Conjugate Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Sanofi Conjugate Vaccine Products Offered
10.3.5 Sanofi Recent Development
10.4 Merck
10.4.1 Merck Company Information
10.4.2 Merck Introduction and Business Overview
10.4.3 Merck Conjugate Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Merck Conjugate Vaccine Products Offered
10.4.5 Merck Recent Development
10.5 Walvax Biotechnology
10.5.1 Walvax Biotechnology Company Information
10.5.2 Walvax Biotechnology Introduction and Business Overview
10.5.3 Walvax Biotechnology Conjugate Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Walvax Biotechnology Conjugate Vaccine Products Offered
10.5.5 Walvax Biotechnology Recent Development
10.6 Royal (Wuxi) Bio-Pharmaceutical
10.6.1 Royal (Wuxi) Bio-Pharmaceutical Company Information
10.6.2 Royal (Wuxi) Bio-Pharmaceutical Introduction and Business Overview
10.6.3 Royal (Wuxi) Bio-Pharmaceutical Conjugate Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Royal (Wuxi) Bio-Pharmaceutical Conjugate Vaccine Products Offered
10.6.5 Royal (Wuxi) Bio-Pharmaceutical Recent Development
10.7 Bharat Biotech
10.7.1 Bharat Biotech Company Information
10.7.2 Bharat Biotech Introduction and Business Overview
10.7.3 Bharat Biotech Conjugate Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Bharat Biotech Conjugate Vaccine Products Offered
10.7.5 Bharat Biotech Recent Development
10.8 Zhifei Biologic
10.8.1 Zhifei Biologic Company Information
10.8.2 Zhifei Biologic Introduction and Business Overview
10.8.3 Zhifei Biologic Conjugate Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Zhifei Biologic Conjugate Vaccine Products Offered
10.8.5 Zhifei Biologic Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Conjugate Vaccine Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Conjugate Vaccine Industrial Chain Analysis
11.4 Conjugate Vaccine Market Dynamics
11.4.1 Conjugate Vaccine Industry Trends
11.4.2 Conjugate Vaccine Market Drivers
11.4.3 Conjugate Vaccine Market Challenges
11.4.4 Conjugate Vaccine Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Conjugate Vaccine Distributors
12.3 Conjugate Vaccine Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Hib Vaccine
Table 2. Major Company of Meningococcal Vaccine
Table 3. Major Company of Pneumococcal Vaccine
Table 4. Major Company of Others
Table 5. Global Conjugate Vaccine Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 6. Global Conjugate Vaccine Sales by Type (2018-2024) & (Million Unit)
Table 7. Global Conjugate Vaccine Sales Market Share in Volume by Type (2018-2024)
Table 8. Global Conjugate Vaccine Sales by Type (2018-2024) & (US& Million)
Table 9. Global Conjugate Vaccine Market Share in Value by Type (2018-2024)
Table 10. Global Conjugate Vaccine Price by Type (2018-2024) & (USD/Unit)
Table 11. Global Conjugate Vaccine Sales by Type (2024-2034) & (Million Unit)
Table 12. Global Conjugate Vaccine Sales Market Share in Volume by Type (2024-2034)
Table 13. Global Conjugate Vaccine Sales by Type (2024-2034) & (US$ Million)
Table 14. Global Conjugate Vaccine Sales Market Share in Value by Type (2024-2034)
Table 15. Global Conjugate Vaccine Price by Type (2024-2034) & (USD/Unit)
Table 16. North America Conjugate Vaccine Sales by Type (2018-2024) & (Million Unit)
Table 17. North America Conjugate Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 18. Europe Conjugate Vaccine Sales (Million Unit) by Type (2018-2024)
Table 19. Europe Conjugate Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 20. Asia-Pacific Conjugate Vaccine Sales (Million Unit) by Type (2018-2024)
Table 21. Asia-Pacific Conjugate Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 22. Latin America Conjugate Vaccine Sales (Million Unit) by Type (2018-2024)
Table 23. Latin America Conjugate Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 24. Middle East and Africa Conjugate Vaccine Sales (Million Unit) by Type (2018-2024)
Table 25. Middle East and Africa Conjugate Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 26. Global Conjugate Vaccine Sales by Company (2018-2024) & (Million Unit)
Table 27. Global Conjugate Vaccine Sales Share by Company (2018-2024)
Table 28. Global Conjugate Vaccine Revenue by Company (2018-2024) & (US$ Million)
Table 29. Global Conjugate Vaccine Revenue Share by Company (2018-2024)
Table 30. Global Market Conjugate Vaccine Price by Company (2018-2024) & (USD/Unit)
Table 31. Global Conjugate Vaccine Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 32. Global Conjugate Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 33. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Conjugate Vaccine as of 2022)
Table 34. Date of Key Manufacturers Enter into Conjugate Vaccine Market
Table 35. Key Manufacturers Conjugate Vaccine Product Type
Table 36. Mergers & Acquisitions, Expansion Plans
Table 37. Global Conjugate Vaccine Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 38. Global Conjugate Vaccine Sales by Region (2018-2024) & (Million Unit)
Table 39. Global Conjugate Vaccine Sales Market Share in Volume by Region (2018-2024)
Table 40. Global Conjugate Vaccine Sales by Region (2018-2024) & (US$ Million)
Table 41. Global Conjugate Vaccine Sales Market Share in Value by Region (2018-2024)
Table 42. Global Conjugate Vaccine Sales (Million Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 43. Global Conjugate Vaccine Sales by Region (2024-2034) & (Million Unit)
Table 44. Global Conjugate Vaccine Sales Market Share in Volume by Region (2024-2034)
Table 45. Global Conjugate Vaccine Sales by Region (2024-2034) & (US$ Million)
Table 46. Global Conjugate Vaccine Sales Market Share in Value by Region (2024-2034)
Table 47. Global Conjugate Vaccine Sales (Million Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2034)
Table 48. Global Conjugate Vaccine Sales by End Users: 2018 VS 2022 VS 2034 (US$ Million)
Table 49. Global Conjugate Vaccine Sales by End Users (2018-2024) & (Million Unit)
Table 50. Global Conjugate Vaccine Sales Market Share in Volume by End Users (2018-2024)
Table 51. Global Conjugate Vaccine Sales by End Users (2018-2024) & (US$ Million)
Table 52. Global Conjugate Vaccine Sales Market Share in Value by End Users (2018-2024)
Table 53. Global Conjugate Vaccine Price by End Users (2018-2024) & (USD/Unit)
Table 54. Global Conjugate Vaccine Sales by End Users (2024-2034) & (Million Unit)
Table 55. Global Conjugate Vaccine Sales Market Share in Volume by End Users (2024-2034)
Table 56. Global Conjugate Vaccine Sales by End Users (2024-2034) & (US$ Million)
Table 57. Global Conjugate Vaccine Sales Market Share in Value by End Users (2024-2034)
Table 58. Global Conjugate Vaccine Price by End Users (2024-2034) & (USD/Unit)
Table 59. North America Conjugate Vaccine Sales by End Users (2018-2024) (Million Unit)
Table 60. North America Conjugate Vaccine Sales by End Users (2018-2024) & (US$ Million)
Table 61. Europe Conjugate Vaccine Sales by End Users (2018-2024) (Million Unit)
Table 62. Europe Conjugate Vaccine Sales by End Users (2018-2024) & (US$ Million)
Table 63. Asia-Pacific Conjugate Vaccine Sales by End Users (2018-2024) (Million Unit)
Table 64. Asia-Pacific Conjugate Vaccine Sales by End Users (2018-2024) & (US$ Million)
Table 65. Latin America Conjugate Vaccine Sales by End Users (2018-2024) (Million Unit)
Table 66. Latin America Conjugate Vaccine Sales by End Users (2018-2024) & (US$ Million)
Table 67. Middle East and Africa Conjugate Vaccine Sales by End Users (2018-2024) (Million Unit)
Table 68. Middle East and Africa Conjugate Vaccine Sales by End Users (2018-2024) & (US$ Million)
Table 69. North America Conjugate Vaccine Sales by Country (2018-2024) & (Million Unit)
Table 70. North America Conjugate Vaccine Sales Market Share in Volume by Country (2018-2024)
Table 71. North America Conjugate Vaccine Sales by Country (2018-2024) & (US$ Million)
Table 72. North America Conjugate Vaccine Sales Market Share in Value by Country (2018-2024)
Table 73. North America Conjugate Vaccine Sales by Country (2024-2034) & (Million Unit)
Table 74. North America Conjugate Vaccine Sales Market Share in Volume by Country (2024-2034)
Table 75. North America Conjugate Vaccine Sales by Country (2024-2034) & (US$ Million)
Table 76. North America Conjugate Vaccine Sales Market Share in Value by Country (2024-2034)
Table 77. Europe Conjugate Vaccine Sales by Country (2018-2024) & (Million Unit)
Table 78. Europe Conjugate Vaccine Sales Market Share in Volume by Country (2018-2024)
Table 79. Europe Conjugate Vaccine Sales by Country (2018-2024) & (US$ Million)
Table 80. Europe Conjugate Vaccine Sales Market Share in Value by Country (2018-2024)
Table 81. Europe Conjugate Vaccine Sales by Country (2024-2034) & (Million Unit)
Table 82. Europe Conjugate Vaccine Sales Market Share in Volume by Country (2024-2034)
Table 83. Europe Conjugate Vaccine Sales by Country (2024-2034) & (US$ Million)
Table 84. Europe Conjugate Vaccine Sales Market Share in Value by Country (2024-2034)
Table 85. Asia-Pacific Conjugate Vaccine Sales by Region (2018-2024) & (Million Unit)
Table 86. Asia-Pacific Conjugate Vaccine Sales Market Share in Volume by Region (2018-2024)
Table 87. Asia-Pacific Conjugate Vaccine Sales by Region (2018-2024) & (US$ Million)
Table 88. Asia-Pacific Conjugate Vaccine Sales Market Share in Value by Region (2018-2024)
Table 89. Asia-Pacific Conjugate Vaccine Sales by Region (2024-2034) & (Million Unit)
Table 90. Asia-Pacific Conjugate Vaccine Sales Market Share in Volume by Region (2024-2034)
Table 91. Asia-Pacific Conjugate Vaccine Sales by Region (2024-2034) & (US$ Million)
Table 92. Asia-Pacific Conjugate Vaccine Sales Market Share in Value by Region (2024-2034)
Table 93. Latin America Conjugate Vaccine Sales by Country (2018-2024) & (Million Unit)
Table 94. Latin America Conjugate Vaccine Sales Market Share in Volume by Country (2018-2024)
Table 95. Latin America Conjugate Vaccine Sales by Country (2018-2024) & (US$ Million)
Table 96. Latin America Conjugate Vaccine Sales Market Share in Value by Country (2018-2024)
Table 97. Latin America Conjugate Vaccine Sales by Country (2024-2034) & (Million Unit)
Table 98. Latin America Conjugate Vaccine Sales Market Share in Volume by Country (2024-2034)
Table 99. Latin America Conjugate Vaccine Sales by Country (2024-2034) & (US$ Million)
Table 100. Latin America Conjugate Vaccine Sales Market Share in Value by Country (2024-2034)
Table 101. Middle East and Africa Conjugate Vaccine Sales by Country (2018-2024) & (Million Unit)
Table 102. Middle East and Africa Conjugate Vaccine Sales Market Share in Volume by Country (2018-2024)
Table 103. Middle East and Africa Conjugate Vaccine Sales by Country (2018-2024) & (US$ Million)
Table 104. Middle East and Africa Conjugate Vaccine Sales Market Share in Value by Country (2018-2024)
Table 105. Middle East and Africa Conjugate Vaccine Sales by Country (2024-2034) & (Million Unit)
Table 106. Middle East and Africa Conjugate Vaccine Sales Market Share in Volume by Country (2024-2034)
Table 107. Middle East and Africa Conjugate Vaccine Sales by Country (2024-2034) & (US$ Million)
Table 108. Middle East and Africa Conjugate Vaccine Sales Market Share in Value by Country (2024-2034)
Table 109. Pfizer Company Information
Table 110. Pfizer Introduction and Business Overview
Table 111. Pfizer Conjugate Vaccine Sales (Million Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 112. Pfizer Conjugate Vaccine Product
Table 113. Pfizer Recent Development
Table 114. GSK Company Information
Table 115. GSK Introduction and Business Overview
Table 116. GSK Conjugate Vaccine Sales (Million Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 117. GSK Conjugate Vaccine Product
Table 118. GSK Recent Development
Table 119. Sanofi Company Information
Table 120. Sanofi Introduction and Business Overview
Table 121. Sanofi Conjugate Vaccine Sales (Million Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 122. Sanofi Conjugate Vaccine Product
Table 123. Sanofi Recent Development
Table 124. Merck Company Information
Table 125. Merck Introduction and Business Overview
Table 126. Merck Conjugate Vaccine Sales (Million Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 127. Merck Conjugate Vaccine Product
Table 128. Merck Recent Development
Table 129. Walvax Biotechnology Company Information
Table 130. Walvax Biotechnology Introduction and Business Overview
Table 131. Walvax Biotechnology Conjugate Vaccine Sales (Million Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 132. Walvax Biotechnology Conjugate Vaccine Product
Table 133. Walvax Biotechnology Recent Development
Table 134. Royal (Wuxi) Bio-Pharmaceutical Company Information
Table 135. Royal (Wuxi) Bio-Pharmaceutical Introduction and Business Overview
Table 136. Royal (Wuxi) Bio-Pharmaceutical Conjugate Vaccine Sales (Million Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 137. Royal (Wuxi) Bio-Pharmaceutical Conjugate Vaccine Product
Table 138. Royal (Wuxi) Bio-Pharmaceutical Recent Development
Table 139. Bharat Biotech Company Information
Table 140. Bharat Biotech Introduction and Business Overview
Table 141. Bharat Biotech Conjugate Vaccine Sales (Million Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 142. Bharat Biotech Conjugate Vaccine Product
Table 143. Bharat Biotech Recent Development
Table 144. Zhifei Biologic Company Information
Table 145. Zhifei Biologic Introduction and Business Overview
Table 146. Zhifei Biologic Conjugate Vaccine Sales (Million Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 147. Zhifei Biologic Conjugate Vaccine Product
Table 148. Zhifei Biologic Recent Development
Table 149. Key Raw Materials Lists
Table 150. Raw Materials Key Suppliers Lists
Table 151. Conjugate Vaccine Market Trends
Table 152. Conjugate Vaccine Market Drivers
Table 153. Conjugate Vaccine Market Challenges
Table 154. Conjugate Vaccine Market Restraints
Table 155. Conjugate Vaccine Distributors List
Table 156. Conjugate Vaccine Downstream Customers
Table 157. Research Programs/Design for This Report
Table 158. Key Data Information from Secondary Sources
Table 159. Key Data Information from Primary Sources
List of Figures
Figure 1. Conjugate Vaccine Product Picture
Figure 2. Global Conjugate Vaccine Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Conjugate Vaccine Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Conjugate Vaccine Sales Status and Outlook (2018-2034) & (Million Unit)
Figure 5. Product Picture of Hib Vaccine
Figure 6. Global Hib Vaccine Sales YoY Growth (2018-2034) & (Million Unit)
Figure 7. Product Picture of Meningococcal Vaccine
Figure 8. Global Meningococcal Vaccine Sales YoY Growth (2018-2034) & (Million Unit)
Figure 9. Product Picture of Pneumococcal Vaccine
Figure 10. Global Pneumococcal Vaccine Sales YoY Growth (2018-2034) & (Million Unit)
Figure 11. Product Picture of Others
Figure 12. Global Others Sales YoY Growth (2018-2034) & (Million Unit)
Figure 13. Global Conjugate Vaccine Sales by Type (2018-2034) & (US$ Million)
Figure 14. Global Conjugate Vaccine Sales Market Share by Type in 2022 & 2034
Figure 15. North America Conjugate Vaccine Sales Market Share in Volume by Type in 2022
Figure 16. North America Conjugate Vaccine Sales Market Share in Value by Type in 2022
Figure 17. Europe Conjugate Vaccine Sales Market Share in Volume by Type in 2022
Figure 18. Europe Conjugate Vaccine Sales Market Share in Value by Type in 2022
Figure 19. Asia-Pacific Conjugate Vaccine Sales Market Share in Volume by Type in 2022
Figure 20. Asia-Pacific Conjugate Vaccine Sales Market Share in Value by Type in 2022
Figure 21. Latin America Conjugate Vaccine Sales Market Share in Volume by Type in 2022
Figure 22. Latin America Conjugate Vaccine Sales Market Share in Value by Type in 2022
Figure 23. Middle East and Africa Conjugate Vaccine Sales Market Share in Volume by Type in 2022
Figure 24. Middle East and Africa Conjugate Vaccine Sales Market Share in Value by Type in 2022
Figure 25. The 5 and 10 Largest Manufacturers in the World: Market Share by Conjugate Vaccine Sales in 2022
Figure 26. The 5 and 10 Largest Manufacturers in the World: Market Share by Conjugate Vaccine Revenue in 2022
Figure 27. Conjugate Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 28. Product Picture of Children
Figure 29. Global Children Sales YoY Growth (2018-2034) & (Million Unit)
Figure 30. Product Picture of Adult
Figure 31. Global Adult Sales YoY Growth (2018-2034) & (Million Unit)
Figure 32. Global Conjugate Vaccine Sales by End Users (2018-2034) & (US$ Million)
Figure 33. Global Conjugate Vaccine Sales Market Share by End Users in 2022 & 2034
Figure 34. North America Conjugate Vaccine Sales Market Share in Volume by End Users in 2022
Figure 35. North America Conjugate Vaccine Sales Market Share in Value by End Users in 2022
Figure 36. Europe Conjugate Vaccine Sales Market Share in Volume by End Users in 2022
Figure 37. Europe Conjugate Vaccine Sales Market Share in Value by End Users in 2022
Figure 38. Asia-Pacific Conjugate Vaccine Sales Market Share in Volume by End Users in 2022
Figure 39. Asia-Pacific Conjugate Vaccine Sales Market Share in Value by End Users in 2022
Figure 40. Latin America Conjugate Vaccine Sales Market Share in Volume by End Users in 2022
Figure 41. Latin America Conjugate Vaccine Sales Market Share in Value by End Users in 2022
Figure 42. Middle East and Africa Conjugate Vaccine Sales Market Share in Value by End Users in 2022
Figure 43. Key Raw Materials Price
Figure 44. Conjugate Vaccine Manufacturing Cost Structure
Figure 45. Conjugate Vaccine Industrial Chain Analysis
Figure 46. Channels of Distribution
Figure 47. Distributors Profiles
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries